Bisphosphonates induce senescence in normal human oral keratinocytes

Journal of Dental Research

Volumn 90, Issue 6, 2011, Pages 810-816

  Kim, R H ^a,b   Lee, R S ^a   Williams, D ^a   Bae, S ^a   Woo, J ^a   Lieberman, M ^a   Oh, J E ^a   Dong, Q ^a   Shin, K H ^a,b   Kang, M K ^a,b   Park, N H ^a,b  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; bisphosphonates; oral fibroblasts; oral keratinocytes; senescence

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; MEVALONIC ACID; PAMIDRONIC ACID;

APOPTOSIS; ARTICLE; CELL AGING; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; FIBROBLAST; HUMAN; KERATINOCYTE; METABOLISM; MOUTH MUCOSA; PRENYLATION; WOUND HEALING;

APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DIPHOSPHONATES; FIBROBLASTS; HUMANS; KERATINOCYTES; MEVALONIC ACID; MOUTH MUCOSA; PRENYLATION; WOUND HEALING;

EID: 79956038937     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034511402995     Document Type: Article

References (30)

1. Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell. 2009 ; 36: 2-14
2. Adornato MC, Morcos I, Rozanski J. The treatment of BP associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc. 2007 ; 138: 971-977
3. Agis H, Blei J, Watzek G, Gruber R. Is zoledronate toxic to human periodontal fibroblasts?. J Dent Res. 2010 ; 89: 40-45
4. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem. 1999 ; 274: 23358-23367
5. Chaturvedi V, Qin JZ, Stennett L, Choubey D, Nickoloff BJ. Resistance to UV-induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53. J Cell Physiol. 2004 ; 198: 100-109 (Pubitemid 38120970)
6. Chen W, Dong Q, Shin KH, Kim RH, Oh JE, Park NH, et al. Grainyhead-like 2 enhances the human telomerase reverse transcriptase gene expression by inhibiting DNA methylation at the 5′-CpG island in normal human keratinocytes. J Biol Chem. 2010 ; 285: 40852-40863
7. de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996 ; 335: 1016-2101
8. Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med. 2009 ; 50: 30-35
9. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010 ; 16: 238-246
10. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010 ; 12: 676-685
11. Kang MK, Guo W, Park N-H. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Differ. 1998 ; 9: 85-95 (Pubitemid 28049531)
12. Kang MK, Kameta A, Shin KH, Baluda MA, Kim HR, Park N-H. Senescence-associated genes in normal human oral keratinocytes. Exp Cell Res. 2003 ; 287: 272-281 (Pubitemid 37323840)
13. Kim RH, Lieberman MB, Lee R, Shin KH, Mehrazarin S, Oh JE, et al. Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-beta signaling. Exp Cell Res. 2010 ; 316: 2600-2608
14. Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, et al. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg. 2008 ; 66: 839-847 (Pubitemid 351522817)
15. Levin L, Laviv A, Schwartz-Arad D. Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment. J Am Dent Assoc. 2007 ; 138: 1218-1220
16. Marshall JK, Thabane M, James C. Randomized active and placebo-controlled endoscopy study of a novel protected formulation of oral alendronate. Dig Dis Sci. 2006 ; 51: 864-868 (Pubitemid 44030804)
17. Mendez MV, Stanley A, Park HY, Shon K, Phillips T, Menzoian JO. Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg. 1998 ; 28: 876-883 (Pubitemid 28521027)
18. O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, et al. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg. 2009 ; 67: 1363-1372
19. Qin JZ, Chaturvedi V, Denning MF, Bacon P, Panella J, Choubey D, et al. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene. 2002 ; 21: 2991-3002 (Pubitemid 34522898)
20. Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?. Bone. 2007 ; 41: 318-320 (Pubitemid 47199147)
21. Reszka AA, Rodan GA. Nitrogen-containing bisphosphonate mechanism of action. Mini Rev Med Chem. 2004 ; 4: 711-719 (Pubitemid 39149473)
22. Rubegni P, Fimiani M. Images in clinical medicine. Bisphosphonate- associated contact stomatitis. N Engl J Med. 2006 ; 355: e25
23. Sanford KK, Evans VJ. A quest for the mechanism of 'spontaneous' malignant transformation in culture with associated advances in culture technology. J Natl Cancer Inst. 1982 ; 68: 895-913 (Pubitemid 12040913)
24. Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 2009 ; 144: 667-676
25. Shin KH, Kang MK, Kim RH, Christensen R, Park NH. Heterogeneous nuclear ribonucleoprotein G shows tumor suppressive effect against oral squamous cell carcinoma cells. Clin Cancer Res. 2006 ; 12: 3222-3228 (Pubitemid 43837373)
26. Stanley A, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg. 2001 ; 33: 1206-1211
27. Van den Wyngaert T, Huizing MT, Vermorken JB. Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?. Ann Oncol. 2006 ; 17: 1197-1204 (Pubitemid 44288209)
28. Wang L, Yang L, Debidda M, Witte D, Zheng Y. Cdc42 GTPase-activating protein deficiency promotes genomic instability and premature aging-like phenotypes. Proc Natl Acad Sci USA. 2007 ; 104: 1248-1253 (Pubitemid 46183990)
29. Watts NB, Becker P. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate. Bone. 1999 ; 24: 65-68 (Pubitemid 28546708)
30. Zanglis A Andreopoulos D Dima M Baltas G Baziotis N (2007). Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: a word of caution. Hell J Nucl Med 10:177-180.